Chapter 1 Novel Drug Delivery Systems Market Overview
1.1 Novel Drug Delivery Systems Definition
1.2 Global Novel Drug Delivery Systems Market Size Status and Outlook (2016-2030)
1.3 Global Novel Drug Delivery Systems Market Size Comparison by Region (2016-2030)
1.4 Global Novel Drug Delivery Systems Market Size Comparison by Type (2016-2030)
1.5 Global Novel Drug Delivery Systems Market Size Comparison by Application (2016-2030)
1.6 Global Novel Drug Delivery Systems Market Size Comparison by Sales Channel (2016-2030)
1.7 Novel Drug Delivery Systems Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Novel Drug Delivery Systems Market Segment Analysis by Player
2.1 Global Novel Drug Delivery Systems Sales and Market Share by Player (2019-2021)
2.2 Global Novel Drug Delivery Systems Revenue and Market Share by Player (2019-2021)
2.3 Global Novel Drug Delivery Systems Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Novel Drug Delivery Systems Market Segment Analysis by Type
3.1 Global Novel Drug Delivery Systems Market by Type
3.1.1 Liposomes
3.1.2 PEGylated Proteins & Polypeptides
3.1.3 Polymer Nanoparticle
3.1.4 Protein?drug Conjugates
3.1.5 Others
3.2 Global Novel Drug Delivery Systems Sales and Market Share by Type (2016-2021)
3.3 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2016-2021)
3.4 Global Novel Drug Delivery Systems Average Price by Type (2016-2021)
3.5 Leading Players of Novel Drug Delivery Systems by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Novel Drug Delivery Systems Market Segment Analysis by Application
4.1 Global Novel Drug Delivery Systems Market by Application
4.1.1 Hospitals & Clinic
4.1.2 Cancer Treatment Centers
4.1.3 Others
4.2 Global Novel Drug Delivery Systems Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Novel Drug Delivery Systems by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Novel Drug Delivery Systems Market Segment Analysis by Sales Channel
5.1 Global Novel Drug Delivery Systems Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Novel Drug Delivery Systems Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Novel Drug Delivery Systems by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Novel Drug Delivery Systems Market Segment Analysis by Region
6.1 Global Novel Drug Delivery Systems Market Size and CAGR by Region (2016-2030)
6.2 Global Novel Drug Delivery Systems Sales and Market Share by Region (2016-2021)
6.3 Global Novel Drug Delivery Systems Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Novel Drug Delivery Systems Market Share by Type
6.4.3 North America Novel Drug Delivery Systems Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Novel Drug Delivery Systems Market Share by Type
6.5.3 Europe Novel Drug Delivery Systems Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Novel Drug Delivery Systems Market Share by Type
6.6.3 Asia-Pacific Novel Drug Delivery Systems Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Novel Drug Delivery Systems Market Share by Type
6.7.3 South America Novel Drug Delivery Systems Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Novel Drug Delivery Systems Market Share by Type
6.8.3 Middle East & Africa Novel Drug Delivery Systems Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Novel Drug Delivery Systems Players
7.1 Amgen
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Teva
7.3 UCB (Union Chimique Belge)
7.4 Roche
7.5 Celgene
7.6 Sanofi
7.7 Merck
7.8 Johnson & Johnson
7.9 Takeda
7.10 Gilead Sciences
7.11 Pfizer
7.12 Dr Reddy
7.13 Samyang Biopharmaceuticals
7.14 TOLMAR
7.15 Astellas
7.16 AMAG?Pharmaceuticals
7.17 AstraZeneca
7.18 AbbVie
7.19 Bausch?Lomb
7.20 TWi Pharmaceuticals
7.21 Novartis
7.22 Aspen
7.23 Shire
7.24 Breckenridge Pharmaceuticals
7.25 Galen
Chapter 8 Upstream and Downstream Analysis of Novel Drug Delivery Systems
8.1 Industrial Chain of Novel Drug Delivery Systems
8.2 Upstream of Novel Drug Delivery Systems
8.3 Downstream of Novel Drug Delivery Systems
Chapter 9 Development Trend of Novel Drug Delivery Systems (2022-2030)
9.1 Global Novel Drug Delivery Systems Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Novel Drug Delivery Systems Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Novel Drug Delivery Systems Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Novel Drug Delivery Systems Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Novel Drug Delivery Systems Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
